Patients on immunosuppressive drugs have been excluded from COVID-19 vaccines trials, creating concerns regarding their efficacy.
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study
Bodini, Giorgia;
2022-01-01
Abstract
Patients on immunosuppressive drugs have been excluded from COVID-19 vaccines trials, creating concerns regarding their efficacy.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
PIIS1590865822006569.pdf
accesso chiuso
Tipologia:
Documento in versione editoriale
Dimensione
697.18 kB
Formato
Adobe PDF
|
697.18 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
